Clinical Trial Update: Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and efficacy of DR-3001 versus placebo in women with overactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• DR-3001

Snippet

Sponsor: Duramed Research | Conditions: Urinary Incontinence | Phase 2 | Status: COMPLETED